Sponsor:
Windsor-Essex Compassionate Care Community
Code:
NCT04825522
Conditions
Spine Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Vancomycin
Brief summary:
Conditions
Spine Disease
Study ID
NCT04825522
Start date
Mar 27, 2022
Status verified date
Apr, 2024
Completion date
Dec 1, 2028
Anticipated
Primary completion date
Dec 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
1643 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Prevention
Arms
no intervention: Control
active comparator: Vancomycin
Interventions
Vancomycin
Primary outcome measure
Central contacts
Abdalla Shamisa, FRCSC
ashamisa@yahoo.caLocations
Windsor Regional Hospital - Ouellette
Recruiting
Windsor, Ontario, Canada, N9A 1E1
Contacts
Abdalla Shamisa, MD
ashamisa@yahoo.caBalraj Jhawar, MD
bsjahwar@gmail.comSponsor
Windsor-Essex Compassionate Care Community
Last update posted
Apr 23, 2024
Last verified
Apr, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Windsor-Essex Compassionate Care Community on 2024-04-23.